Enantioselective Synthesis of 4-Methyl-3,4-dihydroisocoumarin via Asymmetric Hydroformylation of Styrene Derivatives

Article abstract of DOI:10.1021/acs.joc.8b02813

Enantioenriched aldehydes are produced through asymmetric hydroformylation of styrene derivatives using BIBOP-type ligands. The featured example is enantioselective synthesis of 4-methyl-3,4-dihydroisocoumarin, which was prepared in a 95.1:4.9 enantiomeric ratio from asymmetric hydroformylation of ethyl 2-vinylbenzoate followed by in situ lactonization during the reduction process. The conditions are compatible with both electron-rich and electron-poor substituents.

Full text of DOI:10.1021/acs.joc.8b02813

Subscriber access provided by Macquarie University
Note
Enantioselective Synthesis of 4-Methyl-3,4-dihydroisocoumarin
via Asymmetric Hydroformylation of Styrene Derivatives
Bo Qu, Renchang Tan, Madison R. Herling, Nizar Haddad, Nelu
Grinberg, Marisa C Kozlowski, Xumu Zhang, and Chris H. Senanayake
J. Org. Chem., Just Accepted Manuscript • DOI: 10.1021/acs.joc.8b02813 • Publication Date (Web): 19 Feb 2019
Downloaded from http://pubs.acs.org on February 19, 2019
Just Accepted
“Just Accepted” manuscripts have been peer-reviewed and accepted for publication. They are posted
online prior to technical editing, formatting for publication and author proofing. The American Chemical
Society provides “Just Accepted” as a service to the research community to expedite the dissemination
of scientific material as soon as possible after acceptance. “Just Accepted” manuscripts appear in
full in PDF format accompanied by an HTML abstract. “Just Accepted” manuscripts have been fully
peer reviewed, but should not be considered the official version of record. They are citable by the
Digital Object Identifier (DOI®). “Just Accepted” is an optional service offered to authors. Therefore,
the “Just Accepted” Web site may not include all articles that will be published in the journal. After
a manuscript is technically edited and formatted, it will be removed from the “Just Accepted” Web
site and published as an ASAP article. Note that technical editing may introduce minor changes
to the manuscript text and/or graphics which could affect content, and all legal disclaimers and
ethical guidelines that apply to the journal pertain. ACS cannot be held responsible for errors or
consequences arising from the use of information contained in these “Just Accepted” manuscripts.
is published by the American Chemical Society. 1155 Sixteenth Street N.W.,
Washington, DC 20036
Published by American Chemical Society. Copyright © American Chemical Society.
However, no copyright claim is made to original U.S. Government works, or works
produced by employees of any Commonwealth realm Crown government in the course
of their duties.

Page 1 of 14
The Journal of Organic Chemistry
1
2
3
4
5
6
Enantioselective Synthesis of 4-Methyl-3,4-dihydroisocoumarin via
Asymmetric Hydroformylation of Styrene Derivatives
7
8
9
Bo Qu,*,† Renchang Tan,† Madison R. Herling,‡ Nizar Haddad,† Nelu Grinberg,† Marisa C. Kozlowski,‡
Xumu Zhang,§ Chris H. Senanayake*,†,#
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
† Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Rd., Ridgefield,
CT 06877, USA
‡ Department of Chemistry, University of Pennsylvania, Philadelphia, PA 19104, USA
§ Department of Chemistry, Southern University of Science and Technology, Shenzhen, Guangdong,
518055, P. R. China
ABSTRACT
Enantioenriched aldehydes are produced through asymmetric hydroformylation of
styrene derivatives using BIBOP type ligands. The featured example is enantioselective synthesis
of 4-methyl-3,4-dihydroisocoumarin, which was prepared in a 95.1:4.9 enantiomeric ratio from
asymmetric hydroformylation of ethyl 2-vinylbenzoate, then in situ lactonization during
reduction process. The conditions are compatible with both electron-rich and electron-poor
substituents.
3,4-Dihydroisocoumarins and their derivatives are widely present in nature as key
intermediates for the synthesis of biologically active molecules.1 They are regarded as highly
attractive compounds and have many interesting activities.
Naturally occurring 3,4-
dihydroisocoumarins rarely have substitution at the 4-position.2 They, nevertheless, have shown
activities in many different disease areas such as antifungal,3 antimicrobial,4 antimalarial,5 and
insecticidal 6 (Figure 1).
ACS Paragon Plus Environment

The Journal of Organic Chemistry
Page 2 of 14
1
2
3
4
5
6
7
8
9
Figure 1. Representative 4-substituted 3,4-dihydroisocoumarins
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
In view of the relevant importance of these molecules, facile and straightforward
synthetic routes to 4-substituted 3,4-dihydroisocoumarins are highly desirable. Common
methods involve oxidation of methylene groups adjacent to aromatic rings and/or ether oxygen
atoms (Scheme 1a),7 which require the use of often toxic oxidation reagents. Most recently, an
elegant enantioselective synthesis of 4-methyl-3,4-dihydroisocoumarin was reported by
asymmetric hydrogenation of 4-methyl isocoumarin (Scheme 1b).8 Nevertheless, both
approaches require pre-construction of the bicyclic ring structure.7,8
Scheme 1. Synthesis of 4-methyl-3,4-dihydroisocoumarin
a: Selective Oxidation (ref 7)
b: Asymmetric hydrogenation (ref 8)
c. Enantioselective hydroformylation (This work):
Hydroformylation is an industrial process for the production of aldehydes from alkenes
via the net addition of a formyl group and a hydrogen atom to a carbon-carbon double bond.9 A
number of synthetically useful intermediates can be derived from the resulting aldehydes.
ACS Paragon Plus Environment

Page 3 of 14
The Journal of Organic Chemistry
1
2
3
4
5
6
Applications to the synthesis of branched chiral aldehydes with a rhodium catalyst have also
made much progress in recent years10 with the discovery of effective chiral phosphine ligands
including Ph-BPE, Binaphos, Chiraphite, Kelliphite, Yanphos, Duanphos and
7
8
9
bis(diazaphospholane) (BDP) ligands.11-16 The emergence of new ligand scaffolds that affect
rapid, enantioselective, and regioselective hydroformylation provides new strategies for the
efficient synthesis of chiral intermediates which otherwise cannot be accessed readily. Recently
we reported that conformationally rigid bisdihydrobenzooxaphosphole ligands (BIBOPs) are
highly effective and enantioselective for rhodium-catalyzed asymmetric hydroformylation (AHF)
of various mono- and di-substituted alkenes.17 Furthermore, these BIBOP ligands are stable in
air and can be isolated as crystalline solid; which make them conveniently synthesized on
kilogram scales.18 To apply AHF toward the synthesis of highly functionalized intermediates,
we hypothesized that asymmetric hydroformylation of an ortho-ester substituted styrene would
produce an in situ cyclized six-membered chiral lactone during reduction of the aldehyde.
Herein, we report the direct synthesis of highly enantioenriched -methyl substituted 4-methyl-
3,4-dihydroisocoumarin via asymmetric hydroformylation of ethyl 2-vinylbenzoate, followed by
in situ lactonization during a subsequent reduction process.
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Commercially available ethyl 2-vinylbenzoate was selected for the study. It can also be
accessed through vinylation of aryl bromide.19 The reaction was tested in the presence of 0.5
mol% Rh(acac)(CO)2 and 0.6 mol% of (R,R,R,R)-BIBOP ligand, and syn gas pressure of 15/5 bar
of CO/H2 at 60 °C. The starting material fully disappeared as judged by 1H NMR analysis of the
reaction mixture after 20 h. A major aldehyde compound was produced in a branched:linear (b/l)
ratio of 12:1. The unpurified reaction mixture was then reduced with NaBH4 at 0 °C. The
isolated product was confirmed to be 4-methyl 3,4-dihydroisocoumarin 3a with 90% yield and
95.1:4.9 er (Scheme 1c).
The AHF conditions were also applied to other ortho-substituted styrene derivatives
(Table 1). Both electron rich and electron deficient styrene derivatives are compatible under the
reaction conditions. 2-Fluoro styrene produced a high branched:linear ratio of 21.3:1 with
93.1:6.9 er for compound 2b.20 2-Chloro and 2-methoxy styrenes gave similar selectivity at
enantiomeric ratios of 93.9:6.1 and 94.2:5.8, respectively. For CH3 or CF3 substituted styrenes,
same enantioselectivity of the aldehydes was obtained at 93:7 er, but with slightly decreased b/l
ACS Paragon Plus Environment

The Journal of Organic Chemistry
Page 4 of 14
1
2
3
4
5
6
7
8
9
ratios at 4.7:1 and 2.2:1 respectively. The highest b/l ratio was obtained with bis-ortho fluoro-
substituted styrene, where >100:1 of b/l ratio was obtained for 2g. The reduced alcohol product
3g was isolated in 94% yield and 94.5:5.5 er. 1-Vinylnaphthalene was hydroformylated in 5.1:1
of b/l ratio (2h) and an enantiomeric ratio of 89.5:10.5.
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Table 1. AHF of the styrene derivatives
Entry Substrate
Product
yielda b:lb
erc
1
93%
86%
85%
76%
21.3 93.1 : 6.9
9.3 93.9 : 6.1
8.5 94.2 : 5.8
4.7 93.2 : 6.8
2b
2c
2d
2
3
4d
2e
5e
6
55%
94%
72%
2.2
93.0:7.0
2f
>100 94.5 : 5.5
5.1 89.5:10.5
2g
7e
2h
ACS Paragon Plus Environment

Page 5 of 14
The Journal of Organic Chemistry
1
2
3
4
5
6
7
8
9
a All the reactions proceeded at >99% conv. Isolated yields of the branched alcohol products (3b-
3h) after NaBH4 reduction; the corresponding linear products are the main side products. Absolute
stereochemistry was assigned by comparing the sign of the optical rotation with those reported in the
literature. b Determined by 1H NMR spectroscopy on the aldehyde products (2b-2h). c Determined by
Chiral GC and HPLC; same enantioselectivity was observed for the crude aldehyde products and the
reduced products alcohols. d 1.0 mol% Rh(acac)(CO)2, 1.2 mol% (R,R,R,R)-BIBOP. e 1.0 mol%
Rh(acac)(CO)2, 1.2 mol% (R,R,R,R)-MeO-BIBOP.
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
The mechanisms of rhodium catalyzed hydroformylation reactions are complex due to
potentially reversible steps, steps disproportionately affected by CO or H2 pressure, off-cycle
intermediates, and the possibility of multiple selectivity and TOF determining steps.21
A
simplified version of the likely pathway is outlined in Scheme 2a. In related systems,21,22 the
most catalytically relevant steps are alkene coordination, alkene insertion, and CO insertion.
Using a BP86 functional based on a published benchmarking study for related processes,23
alkene insertion was found to be a high energy barrier, whereas the barriers for alkene
coordination and CO insertion were considerably lower. Even so, the reaction of styrene with
D2/CO gave rise to products incorporating hydrogen instead of deuterium and recovered styrene
containing deuterium (see SI), which is consistent with reversibility in the alkene insertion step.
Varying the CO pressure (Scheme 2b) revealed a slight increase in enantioselectivity consistent
with the barriers to alkene insertion becoming higher, and reducing the reversibility.21d In such a
scenario, an energy span analysis is the most accurate protocol to estimate enantioselectivity or
regioselectivity (b/l) by taking into account reversibility.21a However, a much simpler analysis
using the relative transition state energies for the alkene insertion step has been found to provide
a good approximation of these values.21a,23,24
Scheme 2. Mechanism of enantiodetermining olefin insertion in the asymmetric
hydroformylation of styrenea
ACS Paragon Plus Environment

The Journal of Organic Chemistry
Page 6 of 14
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
a Structures in red are calculated. Remaining structures are presented based on reported studies
(see refs 21-24). For clarity, only one structure is shown per intermediate/transition state with the exception
of the alkene insertion where the lowest energy transition states leading to the three possible isomers are
shown.
Thus, the alkene adducts and the alkene insertion step were exhaustively explored with a
total of 16 isomers of the latter being possible, eight that could lead to the chiral branched
aldehyde and eight to linear the aldehyde. Ultimately, eight unique transition states were found
that give the branched aldehyde (Scheme 2). Notably, the ligand was most stable in an
axial/equatorial coordination mode and the lowest energy transition states positioned the hydride
axial which, in turn, dictates approach of the styrene. The amount of (R)-2-phenylpropanal
relative to that of (S)-2-phenylpropanal was calculated via a Boltzmann distribution analysis of
these transition states. The results indicate that the model predicts the stereochemical outcome in
good to excellent agreement with experiment for three substrates (Table 2). The lowest energy
transition state leading to the linear isomer was also located for styrene and when the free energy
was compared to that of the lowest energy branched isomer provided a fair estimate of the b/l
ratios (expt = 10.2:1, computed = 4.3:1).
Table 2. Enantioselectivity predictions for the asymmetric hydroformylation of styrene
derivatives
ACS Paragon Plus Environment

Page 7 of 14
The Journal of Organic Chemistry
1
2
3
4
5
6
7
R
computed era
experimental er
(R):(S)
(R):(S)
83.5:16.5
85.3:14.7b
93.1:6.9
93.4:6.6
Hc
84.9:15.1
8
9
F
CF3
85.5:14.5
83.2:16.8
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
a Calculated from Gibbs free energies obtained using BP86/(cc-pVTZ; Rh: SDD)-IEFPCM-
Toluene // BP86/(6-31G*; Rh: LANL2DZ); b (R,R,R,R)-MeO-BIBOP was used. c Branched:linear ratios:
expt = 10.2:1, computed = 4.3:1.
Our model and a distortion/interaction analysis25 suggests that steric factors are the
dominant control element in the hydroformylation. As shown in the lowest energy transition
states leading to each enantiomer (Figure 2), the (R,R,R,R)-BIBOP ligand promotes asymmetric
hydroformylation by sterically crowding the substrate in transition states leading to the (S)-
enantiomer more significantly than in those leading to the (R)-enantiomer. In Panel A, the (S)-
enantiomer approach places the phenyl group of styrene close to the large tert-butyl group on the
ligand. Conversely, in Panel B, the (S)-enantiomer approach tilts the phenyl group of styrene
away from the tert-butyl group on the ligand, and this structure is consequently more stable by
1.38 kcal/mol. This model also indicates that the position ortho to the phosphorous on the
aromatic rings of the ligand comes in close proximity to the substrate and may be used to
modulate the selectivity. With methoxy groups in these positions (Table 2, entry 1), slightly
higher enantioselectivities were observed, illustrating the potential for exploration of further
ligand variants along these lines.
ACS Paragon Plus Environment

The Journal of Organic Chemistry
Page 8 of 14
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Figure 2. Three-dimensional representations of the computed lowest energy transition states leading to
(S)-2-phenylpropanal (A) and (R)-2-phenylpropanal (B). The red double-headed arrows represent steric
interactions. Both structures were calculated using BP86/(cc-pVTZ; Rh: SDD)-IEFPCM-Toluene //
BP86/(6-31G*; Rh: LANL2DZ).
In summary, asymmetric hydroformylation is an atom-economical homogenous catalytic
process that constructs optically active aldehydes in one step from alkenes in the presence of syn
gas with minimal waste generation. BIBOP ligands have been found as effective in the
enantioselective Rh-catalyzed asymmetric hydroformylation of styrene derivatives.
Enantioenriched 4-methyl-3,4-dihydrocumarine was effectively synthesized from 2-
vinylbenzoate using this method followed by reduction. Styrenes with different substituents
underwent similar transformations. Calculations reveal a very rigid ligand architecture that
reduces conformational freedom and positions the stereogenic tert-butyl groups directly into the
reactive space. The stereochemistry was largely controlled by steric effects between the
approaching styrene and these tert-butyl groups. Interaction with the arene backone of the ligand,
indicate an opportunity for further catalyst engineering to improve outcomes.
EXPERIMENTAL SECTION
General Information. All reactions were carried out under an atmosphere of argon or
nitrogen in dry glassware with magnetic stirring. All commercially available reagents and
1
solvents were used without further purification. H and 13C NMR spectra were recorded
on a Bruker DRX400 MHz or DRX500 MHz spectrometer with TMS as internal reference.
1H NMR data are reported as follows: chemical shift, multiplicity (s = singlet, d = doublet,
ACS Paragon Plus Environment

Page 9 of 14
The Journal of Organic Chemistry
1
2
3
4
5
6
7
8
9
t = triplet, q = quartet, quint = quintet, hex = hexet, m = multiplet, br = broad), coupling
constant, and integration. High resolution mass spectra (HRMS) were obtained on a
Thermo LTQ FT Ultra Mass Spectrometer with heated electrospray ionization (positive),
and using linear ion trap with a Fourier Transform ion cyclotron resonance (FTICR) MS
detector. Chiral analyses were performed on an Agilent HP 1200 Series HPLC system or
on SFC systems.
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
General Procedure for the Asymmetric Hydroformylation. In a glovebox filled with nitrogen, ligand
(0.012 mmol) and [Rh(acac)(CO)2] (0.01 mmol in 0.4 mL toluene) were added to a 2 mL vial. After stirring
for 10 minutes, the substrate (1.0 mmol) and additional solvent were added to bring the total volume of the
reaction mixture to 0.5 mL. The vial was transferred into an autoclave and taken out of the glovebox.
Hydrogen and carbon monoxide were added sequentially. The reaction mixture was stirred at 60 oC for 20
hours under CO/H2 pressure of 15/5 bar. The reaction was then cooled and the pressure was carefully
released in a well-ventilated fume hood. The conversion and branched/linear ratio of this reaction were
determined by 1H NMR spectroscopy from the crude reaction mixture. The reaction vial was then placed
into an ice-water bath, NaBH4 and MeOH were added, after stirring for 30 min, water was added to quench
the reaction. The mixture was extracted with EtOAc 3 times, organic phases were combined and dried with
anhydrous Na2SO4 and concentrated under reduced pressure, the residue was chromatographed on silica
gel to give the pure alcohol products 3a-h. The enantiomeric excess was determined by HPLC or SFC
analysis. For deuterioformylation of styrene, deuterium (5 bar) and carbon monoxide (15 bar) was added
sequentially. The reaction mixture was stirred at 60 oC for 5 hours under CO/D2 pressure of 15/5 bar.
Experimental Data of Products. (R)-4-methylisochroman-1-one (3a). The title compound was prepared
according to the general procedure and purified by column chromatography (hexane/ethyl acetate = 4:1) to
give the product as colorless oil: 146.0 mg, 90% yield, 95.1:4.9 er; HPLC Chiralpak AD-3, isocratic:
heptane/2-propanol = 85/15, flow rate = 0.5 mL/min; λ = 254 nm, retention time: 6.1 min (major), 7.0 min
(minor). NMR data match those reported in the literature.8 1H NMR (500 MHz, CDCl3) δ 8.09 (d, J = 7.8 Hz,
1H), 7.58 (t, J = 7.6 Hz, 1H), 7.39 (t, J = 7.6 Hz, 1H), 7.31 (d, J = 7.7 Hz, 1H), 4.51 (dd, J = 11.0, 4.1 Hz, 1H), 4.24
13
(dd, J = 10.9, 6.6 Hz, 1H), 3.21 – 3.12 (m, 1H), 1.37 (d, J = 7.2 Hz, 3H); C{1H} NMR (126 MHz, CDCl3) δ 165.1,
144.6, 133.9, 130.4, 127.5, 125.7, 124.4, 72.5, 31.7, 16.7. HRMS (ESI) [M+H]+ m/z calcd for [C10H11O2]+ is 163.0754,
found 163.0754.
(R)-2-(2-fluorophenyl)propan-1-ol (3b) The title compound was prepared according to the general procedure
and purified by column chromatography (hexane/ethyl acetate = 4:1) to give the product as colorless oil:
143.4 mg, 93% yield, 93.1:6.9 er; []D22 = +13.97 (c = 1.335 in CHCl3) ([]D25 = +13.5, c = 0.85 in DCM, 95% ee);26
ACS Paragon Plus Environment

The Journal of Organic Chemistry
Page 10 of 14
1
2
3
4
5
6
7
8
9
SFC Chiralpak IC-3, 4.6 mm x 150 mm, temperature: 10 ºC, A: CO2, B: isopropanol, isocratic: A/B: 98.5/1.5,
v/v, flow rate = 2.5 mL/min; λ = 254 nm, retention time: 4.7 min (major), 5.0 min (minor). NMR data match
those reported in the literature.26 1H NMR (400 MHz, CDCl3) δ 7.26 – 7.13 (m, 2H), 7.08 (td, J = 7.5, 1.2 Hz,
1H), 7.00 (ddd, J = 10.4, 8.1, 1.2 Hz, 1H), 3.69 (ddd, J = 17.1, 10.6, 6.9 Hz, 2H), 3.26 (hex, J = 6.9 Hz, 1H), 2.06
(br s, 1H), 1.27 (d, J = 7.1 Hz, 3H); 13C{1H} NMR (101 MHz, CDCl3) δ 161.1 (d, J = 245.0 Hz), 130.6 (d, J = 14.5 Hz),
128.5 (d, J = 5.1 Hz), 127.9 (d, J = 8.4 Hz), 124.2 (d, J = 3.4 Hz), 115.5 (d, J = 22.9 Hz), 67.2, 35.6, 16.6.
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
(R)-2-(2-chlorophenyl)propan-1-ol (3c). The title compound was prepared according to the general
procedure and purified by column chromatography (hexane/ethyl acetate = 4:1) to give the product as
colorless oil: 146.8 mg, 86% yield, 93.9:6.1 er; SFC Chiralpak IC-3, 4.6 mm x 150 mm, temperature: 10 ºC, A:
CO2, B: isopropanol, isocratic: A/B: 98.5/1.5, v/v, flow rate = 2.5 mL/min; λ = 220 nm, retention time: 7.2 min
(major), 7.9 min (minor). NMR data match those reported in the literature.27 1H NMR (400 MHz, CDCl3) δ
7.36 (dd, J = 7.9, 1.2 Hz, 1H), 7.30 – 7.20 (m, 2H), 7.18 – 7.10 (m, 1H), 3.73 (dddd, J = 39.9, 10.8, 6.4, 1.5 Hz, 2H),
3.52 (hex, J = 6.7 Hz, 1H), 1.71 (br s, 1H), 1.28 (d, J = 7.0 Hz, 3H); 13C{1H} NMR (101 MHz, CDCl3) δ 140.9, 134.3,
129.7, 127.6, 127.6, 127.1, 67.1, 38.1, 16.8.
(R)-2-(2-methoxyphenyl)propan-1-ol (3d). The title compound was prepared according to the general
procedure and purified by column chromatography (hexane/ethyl acetate = 4:1) to give the product as
colorless oil: 141.3 mg, 85% yield, 94.2:5.8 er; SFC Chiralpak IC-3, 4.6 x 150 mm: 10 ºC, A: CO2, B:
isopropanol; isocratic: A/B: 99/1, v/v, flow rate 2.5 mL/min, λ = 220 nm, retention time: 13.0 min (major),
14.5 min (minor). NMR data match those reported in the literature.28 1H NMR (400 MHz, CDCl3) δ 7.25 –
7.16 (m, 2H), 6.98 – 6.90 (m, 1H), 6.87 (d, J = 8.4 Hz, 1H), 3.81 (s, 3H), 3.77 – 3.61 (m, 2H), 3.47 – 3.36 (m, 1H),
13
1.74 (br s, 1H), 1.25 (d, J = 7.1 Hz, 3H); C{1H} NMR (101 MHz, CDCl3) δ 157.3, 131.8, 127.4, 127.4, 120.8, 110.6,
67.8, 55.4, 35.2, 16.6.
(R)-2-(2-(trifluoromethyl)phenyl)propan-1-ol (3e). The title compound was prepared according to the general
procedure and purified by column chromatography (hexane/ethyl acetate = 4:1) to give the product as
colorless oil: 155.2 mg, 76% yield, 93.2:6.8 er; SFC Chiralpak IC-3, 4.6 x 150 mm: 10 ºC, A: CO2, B:
isopropanol; isocratic: A/B: 98.5/1.5, v/v, flow rate 2.5 mL/min, λ = 220 nm, retention time: 2.6 min
(major), 2.8 min (minor). 1H NMR (400 MHz, CDCl3) δ 7.64 (d, J = 7.9 Hz, 1H), 7.53 (t, J = 7.5 Hz, 1H), 7.45 (d,
J = 7.8 Hz, 1H), 7.31 (t, J = 7.6 Hz, 1H), 3.84 – 3.65 (m, 2H), 3.41 (hex, J = 7.0 Hz, 1H), 1.59 (br s, 1H), 1.29 (d, J =
13
6.9 Hz, 3H); C{1H} NMR (101 MHz, CDCl3) δ 143.2, 132.0, 128.7 (d, J = 6.0 Hz), 127.7, 126.3, 125.9 (d, J = 6.0
Hz), 123.2 (q, J = 271.8 Hz), 67.9, 37.4 (d, J = 1.5 Hz), 18.5. HRMS (ESI) [M+NH4]+ m/z calcd for [C10H15ONF3]+
is 222.1100, found 222.1101.
(R)-2-(o-tolyl)propan-1-ol (3f). The title compound was prepared according to the general procedure and
purified by column chromatography (hexane/ethyl acetate = 4:1) to give the product as pale brown oil: 82.6
ACS Paragon Plus Environment

Page 11 of 14
The Journal of Organic Chemistry
1
2
3
4
5
6
7
8
9
mg, 55% yield, 93.0:7.0 er; Aquity UPLC Lux 3 Amylose-1, 3.0 x 150 mm, 10 ºC, A: CO2, B: isopropanol;
Isocratic: A/B: 99.7/0.3, v/v, flow rate 2.5 mL/min, λ = 220 nm, retention time: 3.7 min (minor), 4.1 min
(major). NMR data match those reported in the literature.26,28 1H NMR (400 MHz, CDCl3) δ 7.20 (m, 1H),
7.18 (d, J = 7.4 Hz, 1H), 7.13 (m, 2H), 3.72 (m, 2H), 3.28 (m, 1H), 2.35 (s, 3H), 1.58 (br s, 1H), 1.24 (d, J = 8.0 Hz,
3H); 13C{1H} NMR (101 MHz, CDCl3) δ 141.8, 136.4, 130.5, 126.4, 126.3, 125.5, 68.0, 37.2, 19.6, 17.6.
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
(R)-2-(2,6-difluorophenyl)propan-1-ol (3g). The title compound was prepared according to the general
procedure and purified by column chromatography (hexane/ethyl acetate = 4:1) to give the product as
colorless oil: 161.8 mg, 94% yield, 94.5:5.5 er; SFC Chiralpak OD-3, 4.6 x 150 mm: 10 ºC, A: CO2, B:
isopropanol; isocratic: A/B: 99/1, v/v, flow rate 2.5 mL/min, λ = 220 nm, retention time: 4.0 min (major),
4.6 min (minor). 1H NMR (500 MHz, CDCl3) δ 7.16 – 7.11 (m, 1H), 6.85 – 6.82 (m, 2H), 3.85 – 3.77 (m, 2H),
3.45 (hex, J = 7.2 Hz, 1H), 2.05 (br s, 1H), 1.32 (d, J = 7.2 Hz, 3H); 13C{1H} NMR (126 MHz, CDCl3) δ 162.8 (d, J =
9.4 Hz), 160.9 (d, J = 9.3 Hz), 127.9 (t, J = 10.6 Hz), 119.0 (t, J = 18.2 Hz), 111.6 (d, J = 5.8 Hz), 111.5 (d, J = 5.8 Hz),
66.0 (d, J = 2.5 Hz), 33.1, 15.7 (t, J = 2.5 Hz). HRMS (ESI) [M+NH4]+ m/z calcd for [C9H14ONF2]+ is 190.1038,
found 190.1039.
(R)-2-(naphthalen-1-yl)propan-1-ol (3h). The title compound was prepared according to the general
procedure and purified by column chromatography with 100% dicholoromethane to give the product as
colorless oil: 134 mg, 72% yield, 89.5:10.5 er; SFC Chiralpak IC-3, 4.6 x 150 mm: 10 ºC, A: CO2, B: isopropanol;
isocratic: A/B: 97/3, v/v, flow rate 2.5 mL/min, λ = 220 nm, retention time: 14.5 min (minor), 15.9 min
1
(major). NMR data matches to those reported.26,28 1H NMR (500 MHz, CDCl3) H NMR: (500 MHz, CDCl3):
8.16 (d, J = 8.5 Hz, 1H), 7.88 (d, J = 8.1 Hz, 1H), 7.76 (d, J = 8.4 Hz, 1H), 7.50 (m, 4 H), 3.95 (m, 1H), 3.89 (m, 2
H), 1.45 (d, J = 6.7 Hz, 3H), 1.37 (br s, 1H). 13C{1H} NMR: (126 MHz, CDCl3): 139.5, 134.0, 131.9, 129.0, 127.1, 126.0,
125.5, 123.05, 123.04, 68.1, 36.4, 17.8.
ASSOCIATED CONTENT
Supporting Information
The Supporting Information is available free of charge on the ACS Publication website
HPLC, NMR spectra and calculation data (PDF)
AUTHOR INFORMATION
Corresponding Authors
* E-mail: bo.qu@boehringer-ingelheim.com (B. Qu)
* E-mail: chris@astatech.com.cn (C. Senanayake)
# Current address: Astatech BioPharmaceutical Corporation, 488 Kelin West Road, Wenjiang
Dist., Chengdu, Sichuan 611130, P. R. China
ACS Paragon Plus Environment

The Journal of Organic Chemistry
Page 12 of 14
1
2
3
4
ORCID
5
6
7
8
Bo Qu: 0000-0001-7347-0108
Marisa Kozlowski: 0000-0002-4225-7125
Xumu Zhang: 0000-0001-5700-0608
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Notes
The authors declare no competing financial interest.
REFERENCES
(1) Braca, A.; Bader, A.; De Tommasi, N. Plant and Fungi 3,4-Dihydroisocoumarins: Structures,
Biological Activity, and Taxonomic Relationship. Stud. Nat. Prod. Chem. 2012, 37, 191–215.
(2) Qi, J.; Shao, C.-L.; Li, Z.-Y.; Gan, L.-S.; Fu, X.-M.; Bian, W.-T.; Zhao, H.-Y.; Wang, C.-Y.
Isocoumarin Derivatives and Benzofurans from a Sponge-Derived Penicillium sp. Fungus. J. Nat.
Prod. 2013, 76, 571−579.
(3) Nozawa, K.; Yamada, M.; Tsuda, Y.; Kawai, K.; Nakajima, S. Synthesis of Antifungal
Isocoumarins. III. Synthesis and Antifungal Activity of 3-Aryl-3,4-dihydro-4-substituted-
isocoumarins. Chem. Pharm. Bull. 1981, 29, 3486−3493.
(4) Bogdanov, M. G.; Kandinska, M. I.; Dimitrova, D. B.; Gocheva, B. T.; Palamareva, M. D.
Preliminary Evaluation of Antimicrobial Activity of Diastereomeric cis/trans-3-Aryl(Heteroaryl)-
3,4-dihydroisocoumarin-4-carboxylic Acids. Z. Naturforsch. 2007, 62c, 477−482.
(5) Cedrón, J. C.; Gutiérrez, D.; Flores, N.; Ravelo, Á. G.; Estévez-Braun, A. Preparation and
antimalarial activity of semisynthetic lycorenine derivatives. Eur. J. Med. Chem. 2013, 63, 722–
730.
(6) Ozoe, Y.; Kuriyama, T.; Tachibana, Y.; Harimaya, K.; Takahashi, N.; Yaguchi, T.; Suzuki, E.;
Imamura, K.; Oyama, K. Isocoumarin Derivative as a Novel GABA Receptor Ligand from
Neosartorya quadricincta. J. Pestic. Sci., 2004, 29, 328–331.
(7) (a) Zhang, Z.; Gao, Y.; Liu, Y.; Li, J.; Xie, H.; Li, H.; Wang, W. Organocatalytic Aerobic
Oxidation of Benzylic sp3 C–H Bonds of Ethers and Alkylarenes Promoted by a Recyclable
TEMPO Catalyst. Org. Lett. 2015, 17, 5492−5495. (b) Gonzalez-de-Castro, A.; Robertson, C. M.;
Xiao, J. Dehydrogenative α-Oxygenation of Ethers with an Iron Catalyst. J. Am. Chem. Soc. 2014,
136, 8350–8360. (b)
(8) Li, W.; Wiesenfeldt, M. P.; Glorius, F. Ruthenium−NHC−Diamine Catalyzed Enantioselective
Hydrogenation of Isocoumarins. J. Am. Chem. Soc. 2017, 139, 2585−2588.
(9) Bohnen, H.-W.; Cornils, B. Hydroformylation of Alkenes: An Industrial View of the Status and
Importance. Adv. Catal. 2002, 47, 1−64.
(10) For representative reviews, see(a) Klosin, J.; Landis, C. R. Ligands for Practical Rhodium-
Catalyzed Asymmetric Hydroformylation. Acc. Chem. Res. 2007, 40, 1251−1259. (b) Franke, R.;
Selent, D.; Börner, A. Applied Asymmetric Hydroformylation. Chem. Rev. 2012, 112, 5675−5732.
(c) Brezny, A. C.; Landis, C. R. Recent Developments in the Scope, Practicality, and Mechanistic
Understanding of Enantioselective Hydroformylation Recent Developments in the Scope,
ACS Paragon Plus Environment

Page 13 of 14
The Journal of Organic Chemistry
1
2
3
4
5
Practicality, and Mechanistic Understanding of Enantioselective Hydroformylation. Acc. Chem. Res.
2018, 51, 2344−2354, and references cited therein
(11) (a) Whiteker, G. T.; Briggs, J. R.; Babin, J. E.; Barner, B. A. Asymmetric Catalysis Using
Bisphosphite Ligands, in Chemical Industries. Marcel Dekker: New York, 2003; Vol. 89, 359−367.
(b) Babin, J. E.; Whiteker, G. T. Asymmetric Synthesis. WO 9303839, 1993.
6
7
8
9
(12) Cobley, C. J.; Gardner, K.; Klosin, J.; Praquin, C.; Hill, C.; Whiteker, G. T.; Zanotti-Gerosa, A.;
Petersen, J. L.; Abboud, K. A. Synthesis and Application of a New Bisphosphite Ligand Collection
for Asymmetric Hydroformylation of Allyl Cyanide. J. Org. Chem. 2004, 69, 4031−4040.
(13) Yan, Y.; Zhang, X. A Hybrid Phosphorus Ligand for Highly Enantioselective Asymmetric
Hydroformylation. J. Am. Chem. Soc. 2006, 128, 7198−7202.
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
(14) (a) Abrams, M. L.; Foarta, F.; Landis, C. R. Asymmetric Hydroformylation of Z-Enamides and
Enol Esters with Rhodium-Bisdiazaphos Catalysts. J. Am. Chem. Soc. 2014, 136, 14583−14588. (b)
Clark, T. P.; Landis, C. R.; Freed, S. L.; Klosin, J.; Abboud, K. A. Highly Active, Regioselective,
and Enantioselective Hydroformylation with Rh Catalysts Ligated by Bis-3,4-diazaphospholane. J.
Am. Chem. Soc. 2005, 127, 5040-5042.
(15) Wang, X.; Buchwald, S. L. Synthesis of Optically Pure 2-Trifluoromethyl Lactic Acid by
Asymmetric Hydroformylation. J. Org. Chem. 2013, 78, 3429−3433.
(16) Yu, Z.; Eno, M. S.; Annis, A. H.; Morken, J. P. Enantioselective Hydroformylation of 1-Alkenes
with Commercial Ph-BPE Ligand. Org. Lett. 2015, 17, 3264−3267.
(17) Tan, R.; Zheng, X.; Qu, B; Sader, C. A.; Fandrick, K. R.; Senanayake, C. H.; Zhang, X. Tunable P-
Chiral Bisdihydrobenzooxaphosphole Ligands for Enantioselective Hydroformylation. Org. Lett.
2016, 18, 3346−3349.
(18) (a) Li, W.; Rodriguez, S.; Duran, A.; Sun, X.; Tang, W.; Premasiri, A.; Wang, J.; Sidhu, K.; Patel,
N. D.; Savoie, J.; Qu, B.; Lee, H.; Haddad, N.; Lorenz, J. C.; Nummy, L.; Hossain, A.; Yee, N.; Lu,
B.; Senanayake, C. H. The P-Chiral Phosphane Ligand (MeO-BIBOP) for Efficient and Practical
Large-Scale Rh-Catalyzed Asymmetric Hydrogenation of N-Acetyl Enamides with High TONs.
Org. Process Res. Dev. 2013, 17, 1061−1065. (b) Tang, W.; Qu, B.; Capacci, A. G.; Rodriguez, S.;
Wei, X.; Haddad, N.; Narayanan, B.; Ma, S.; Grinberg, N.; Yee, N. K.; Krishnamurthy, D.;
Senanayake, C. H. Novel, Tunable, and Efficient Chiral Bisdihydrobenzooxaphosphole Ligands for
Asymmetric Hydrogenation. Org. Lett. 2010, 12, 176−179.
(19) Denmark, S. E.; Butler, C. R. Vinylation of Aryl Bromides Using an Inexpensive
Vinylpolysiloxane. Org. Lett. 2006, 8, 63−66.
(20) Asymmetric hydroformylation of o-fluoro styrene using Yanphos ligand was reported to produce
2b in 99:1 er and 10.1:1 b/l ratio in benzene: see ref 13.
(21) (a) Dingwall, P.; Fuentes, J. A.; Crawford, L.; Slawin, A. M. Z.; Bühl, M.; Clarke, M. L.
Understanding a Hydroformylation Catalyst that Produces Branched Aldehydes from Alkyl
Alkenes. J. Am. Chem. Soc. 2017, 139, 15921−15932. (b) Brezny, A. C.; Landis, C. R. Unexpected
CO Dependencies, Catalyst Speciation, and Single Turnover Hydrogenolysis Studies of
Hydroformylation via High Pressure NMR Spectroscopy. J. Am. Chem. Soc. 2017, 139,
2778−2785. (c) Nelsen, E. R.; Brezny, A. C.; Landis, C. R. Interception and Characterization of
Catalyst Species in Rhodium Bis(diazaphospholane)-Catalyzed Hydroformylation of Octene, Vinyl
Acetate, Allyl Cyanide, and 1-Phenyl-1,3-butadiene. J. Am. Chem. Soc. 2015, 137 (44),
14208−14219. (d) Watkins, A. L.; Landis, C. R. Origin of Pressure Effects on Regioselectivity and
ACS Paragon Plus Environment

The Journal of Organic Chemistry
Page 14 of 14
1
2
3
4
5
6
7
8
9
Enantioselectivity in the Rhodium-Catalyzed Hydroformylation of Styrene with (S,S,S)-
BisDiazaphos. J. Am. Chem. Soc. 2010, 132, 10306−10317.
(22) Gellrich, U.; Seiche, W.; Keller, M.; Breit, B. Mechanistic Insights into a Supramolecular Self-
Assembling Catalyst System: Evidence for Hydrogen Bonding during Rhodium-Catalyzed
Hydroformylation. Angew. Chem. Int. Ed. 2012, 51, 11033−11038.
(23) Silva, V. D.; Dias, R. P.; Rocha, W. R. Insertion reaction of ethylene into the Rh-H bond: A
comparative theoretical study. Chem. Phys. Lett. 2007, 439, 69−75.
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
(24) (a) Lei, M.; Wang, Z.; Du, X.; Zhang, X.; Tang, Y. Asymmetric Hydroformylation Catalyzed by
RhH(CO)2[(R,S)-Yanphos]: Mechanism and Origin of Enantioselectivity. J. Phys. Chem. A 2014,
118, 8960−8970. (b) Wassenaar, J.; de Bruin, B.; Reek, J. N. H. Rhodium-Catalyzed Asymmetric
Hydroformylation with Taddol-Based IndolPhos Ligands. Organometalics 2010, 29, 2767−2776.
(c) Gleich, D.; Schmid, R.; Herrmann, W. A. A Molecular Model To Explain and Predict the
Stereoselectivity in Rhodium-Catalyzed Hydroformylation. Organometallics 1998, 17, 2141−2143.
(25) Bickelhaupt, F. M.; Houk, K. N. Analyzing Reaction Rates with the Distortion/Interaction-
Activation Strain Model. Angew. Chem. Int. Ed. 2017, 56, 10070–10086.
(26) Allmendinger, S.; Hirotaka, K.; Bernhard, B. Easily Accessible TADDOL-Derived Bisphosphonite
Ligands: Synthesis and Application in the Asymmetric Hydroformylation of Vinylarenes. Adv.
Synth. Catal. 2015, 357, 41−45.
(27) Cheung, L. L. W.; Vasapollo, G.; Howard, A. Synthesis of Alcohols via a Rhodium-Catalyzed
Hydroformylation - Reduction Sequence using Tertiary Bidentate Amine Ligands. Adv. Synth.
Catal. 2012, 354, 2019−2022.
(28) Denmark, S. E.; Werner, N. S. On the Stereochemical Course of the Palladium-Catalyzed Cross-
Coupling of Allylic Silanolate Salts with Aromatic Bromides. J. Am. Chem. Soc. 2010, 132,
3612−3620.
ACS Paragon Plus Environment